Your session is about to expire
← Back to Search
Autologous Blood Patch for Lung Cancer
N/A
Waitlist Available
Led By Christopher Seder, MD
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients who underwent elective wedge resection, segmentectomy, lobectomy, or bilobectomy for suspected non-small cell lung cancer
Patients who have an air leak on the morning of postoperative Day 3
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 30 days
Awards & highlights
Study Summary
This trial examines whether ABP is effective in preventing a prolonged air leak after lung resection for cancer.
Who is the study for?
This trial is for adults over 18 who had lung cancer surgery and have an air leak on the third day after their operation. It's not for those who had more extensive surgeries like pneumonectomy, or women who are pregnant.Check my eligibility
What is being tested?
The study tests if using a patient's own blood to create a patch (ABP) can prevent leaks in the lungs after cancer surgery. Patients will either get this new treatment or the usual care, and researchers will compare how well each works.See study design
What are the potential side effects?
While specific side effects of ABP aren't detailed, it may include discomfort at the blood draw site, infection risk, and potential breathing issues related to procedure complications.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I had surgery to remove part of my lung for suspected lung cancer.
Select...
I have an air leak from my surgery site on the third day after surgery.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 30 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 30 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
30-day Mortality
Hospital Length of Stay
In hospital mortality
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Autologous Blood PatchExperimental Treatment1 Intervention
Group II: Standard of Care (Per physician)Active Control1 Intervention
Find a Location
Who is running the clinical trial?
Rush University Medical CenterLead Sponsor
418 Previous Clinical Trials
162,439 Total Patients Enrolled
Christopher Seder, MDPrincipal InvestigatorRush University Medical Center
Sebastien Gilbert, MDStudy DirectorUniversity of Ottawa
3 Previous Clinical Trials
406 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently pregnant.I had surgery to remove part of my lung for suspected lung cancer.I have an air leak from my surgery site on the third day after surgery.I am 18 years old or older.I am 18 years old or younger.I have had surgery to remove a lung, part of a lung, chest wall, diaphragm, or had surgery on both sides of my chest.
Research Study Groups:
This trial has the following groups:- Group 1: Autologous Blood Patch
- Group 2: Standard of Care (Per physician)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is it possible to register for this clinical investigation at the present time?
"Clinicaltrials.gov states that this research project is not admitting participants at the moment. The initial posting of this trial was on July 1st 2021 and it has been updated most recently on July 19th 2022, but there are 397 other active studies recruiting people as we speak."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger